HER2 Support Group Forums - View Single Post - FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrenc

News · 07-17-2017, 09:42 PM

The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer.

More...

07-17-2017, 09:42 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,950	FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrenc The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. More...